1 January 2009 Colloidal mesoporous silica nanoparticles with protoporphyrin IX encapsulated for photodynamic therapy
Author Affiliations +
Abstract
Protoporphyrin IX (PpIX)-encapsulated mesoporous silica nanoparticles were synthesized, characterized, and utilized for photodynamic therapy (PDT) of cancer. Silica encapsulation is relatively transparent for activated light and can protect the PpIX against denaturation induced by the extreme bioenvironment. The mesoporous silica can also ensure that the encapsulated PpIX can be well-contacted with oxygen, stimulated, and released. PpIX-encapsulated colloidal mesoporous silica nanoparticles were uptaken by tumor cells in vitro, and the effect of photon-induced toxicity was demonstrated after comparison with some control experiments. The surface of PpIX-encapsulated silica nanoparticles can be grafted with appropriate functionalized groups and conjugated with certain biomolecules for specific targeting.
© (2009) Society of Photo-Optical Instrumentation Engineers (SPIE)
Jun Qian, Arash Gharibi, Sailing He, "Colloidal mesoporous silica nanoparticles with protoporphyrin IX encapsulated for photodynamic therapy," Journal of Biomedical Optics 14(1), 014012 (1 January 2009). https://doi.org/10.1117/1.3083427 . Submission:
JOURNAL ARTICLE
6 PAGES


SHARE
Back to Top